Advertisement

Reactions Weekly

, Volume 1735, Issue 1, pp 163–163 | Cite as

Ipilimumab/pembrolizumab

Inflammatory polyarthritis: case report
Case report
  • 3 Downloads

Reference

  1. Oke AR, et al. Successful use of adalimumab in immune checkpoint inhibitor-associated inflammatory arthritis. Rheumatology Advances in Practice 2: 1-2, No. 1, Jan 2018. Available from: URL: http://doi.org/10.1093/rap/rky001 - UnitedKingdom

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations